|
|
Space Shuttle - STS 112 (111) - Atlantis (026)
Nutzlast & ExperimenteDeployable Payloads
Detailed Test Objectives (DTOs)
|
|
Space Station RMS Dynamic Model Validation (DTO 264)
|
|
Single-String Global Positioning System (DTO 700-14/PGSC, GPS)
|
|
Crosswind Landing Performance (DTO 805)
|
| | |
Detailed Supplementary Objectives (DSOs)
|
|
Bioavailability and Performance Effects of Promethazine During Spaceflight, Protocol B (DSO 490-B)
|
|
Monitoring Latent Virus Reactivation and Shedding in Astronauts (DSO 493)
|
|
Space Flight and Immune Function (DSO 498)
|
|
Eye Movements and Motion Perception Induced by Off-Vertical Axis Rotation (OVAR) at Small Angles of Tilt After Spaceflight (DSO 499)
|
|
Effects of Short-Duration Space Flight on Type 1/Type 2 Cytokine Balance and Ist Endocrine Regulation (DSO 501)
|
|
Test of Midodrine as a Counteractive Measure Against Postflight Orthostatic Hypotension (DSO 503-S)
|
|
Sleep-Wake Actigraphy and Light Exposure During Spaceflight (DSO 634)
|
|
Spatial Reorientation Following Space Flight (DSO 635)
|
|
Ram Burn Observations (RAMBO)
|
| | |
|
|
|
|